|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
|
Fig. 5. Persistent Fgf signalling is required for maintenance of myod
expression and normal fast muscle differentiation. (A) Schematic showing
timecourse of SU5402 treatment regimes (C,D,F,G,I,J,L,M) and control vehicle
treatment (B,E,H,K). (B) Around 9 s, myod expression is clearly
visible in each nascent somite (arrowheads). (C) Treatment with SU5402 for 30
minutes substantially reduces lateral myod expression (arrowheads).
(D) Pre-treatment for 1 hour prevents all lateral expression (arrowheads).
Inset in D shows adaxial myod expression in tailbud. (E) At 10-12 s,
myod expression is well established in lateral cells of all somites.
(F) Exposure to SU5402 for 30 minutes reduces lateral myod expression
without noticeable effect on adaxial expression. (E-G) Dorsal flatmounts of
posterior embryo (right) with nascent somites shown at high magnification
(left). (G) Pre-treatment for 1 hour essentially ablates lateral myod
expression. (H,I) SU5402 treatment for 2.5 hours from 10 s (I) abolishes new
myod stripes (I, arrowheads; compare with control in H), but has less
effect in anterior somites (arrows). Dorsal views of whole mount (left) and
flat mount (right). There is similar expression in rostralmost somites (white
arrows). (J) SU5402 treatment for 2.5 hours, followed by a 2-hour wash-out
permits recovery of myod-expressing stripes in more than the four
newly-formed somites (arrowheads). (K) At 23 s, mylz2 expression
reveals abundant differentiated fast muscle. Lateral view, dorsal towards the
left. (L,M) Moderate (L; 27/36 treated embryos) and severe (M; 5/36) examples
of effect of late SU5402 application at 18 s to otherwise wild-type embryos.
Anterior is towards top in all panels.
|
